- Statins: renoprotective or nephrotoxic ?2008 | First Faculty of Medicine
- Renoprotection Provided by Additional Diuretic Treatment in Partially Nephrectomized Ren-2 Transgenic Rats Subjected to the Combined RAS and ETA Blockade2019 | Third Faculty of Medicine
- Renoprotective effects of SGLT2 inhibitors - gliflozins2021 | First Faculty of Medicine
- Renoprotective action of antihypertensive drugs2004 | First Faculty of Medicine
- Renoprotective characteristics of ACE inhibitors2004 | First Faculty of Medicine
- Are angiotensin II antagonists renoprotective (in Czech)?2000 | First Faculty of Medicine
- Empagliflozin Is Not Renoprotective in Non-Diabetic Rat Models of Chronic Kidney Disease2022 | Third Faculty of Medicine
- Endothelin antagonist - new class of potential renoprotective drugs2013 | First Faculty of Medicine
- Renoprotective Effect of Agalsidase Alfa: A Long-Term Follow-Up of Patients with Fabry Disease2022 | First Faculty of Medicine
- Inhibition of soluble epoxide hydrolase is renoprotective in 5/6 nephrectomized Ren-2 transgenic hypertensive rats2014 | First Faculty of Medicine, Second Faculty of Medicine, Third Faculty of Medicine
- Cardioprotective and renoprotective characteristics of ACE inhibitors. Imdidapril - ACE inhibitor of the new generation2004 | First Faculty of Medicine
- High dose of angiotensin antagonist may be more renoprotective compared to standard dose. Commentary2006 | First Faculty of Medicine
- Similar renoprotection after renin-angiotensin-dependent and -independent antihypertensive therapy in 5/6-nephrectomized Ren-2 transgenic rats: are there blood pressure-independent effects?2010 | Second Faculty of Medicine, Third Faculty of Medicine
- Paricalcitol lowers proteinuria in chronic renal failure and could be renal protective.Commentary on:AJKD 54,2009,647-622010 | First Faculty of Medicine
- The renoprotective effects of canagliflozin demonstrated in the CREDENCE study cannot yet be considered as an effect of the whole class of SGLT2 inhibitors2020 | Second Faculty of Medicine
- Renoprotective Effects of ETA Receptor Antagonists Therapy in Experimental Non-Diabetic Chronic Kidney Disease: Is There Still Hope for the Future?2018 | Third Faculty of Medicine
- Expert opinion on the cooperation of diabetologists and internists with nephrologists in the care of patients with chronic kidney diseases +12022 | First Faculty of Medicine, Third Faculty of Medicine
- Expert opinion on the cooperation of diabetologists and internists with nephrologists in the care of patients with chronic kidney diseases +12022 | First Faculty of Medicine, Central Library of Charles University, Third Faculty of Medicine
- Antihypertensive and renoprotective actions of soluble epoxide hydrolase inhibition in ANG II-dependent malignant hypertension are abolished by pretreatment with L-NAME2013 | Central Library of Charles University, Second Faculty of Medicine, Third Faculty of Medicine
- Endothelin type A receptor blockade increases renoprotection in congestive heart failure combined with chronic kidney disease: Studies in 5/6 nephrectomized rats with aorto-caval fistula2023 | Central Library of Charles University, Second Faculty of Medicine
- Commentary on AVOID study2009 | First Faculty of Medicine
- Addition of ETA receptor blockade increases renoprotection provided by renin-angiotensin system blockade in 5/6 nephrectomized Ren-2 transgenic rats2014 | First Faculty of Medicine, Third Faculty of Medicine
- Combined Inhibition of Soluble Epoxide Hydrolase and Renin-Angiotensin System Exhibits Superior Renoprotection to Renin-Angiotensin System Blockade in 5/6 Nephrectomized Ren-2 Transgenic Hypertensive Rats with Established Chronic Kidney Disease2018 | First Faculty of Medicine, Central Library of Charles University, Second Faculty of Medicine, Third Faculty of Medicine
- Diabetes mellitus, hypertension and kidney2008 | First Faculty of Medicine
- The effect of treatment with angiotenzin - converting enzyme inhibitors and angiotensin antagonist on progression of chronic nephropathy2002 | First Faculty of Medicine
- Progression of Cronic Renal Insufficiency and Possibilities to Influence it by Inhibitors of the Angiotensin Convrting Enzyme and Angiotensin Antagonists2003 | First Faculty of Medicine
- Lercanidipine in a new combination2011 | Third Faculty of Medicine
- Ivabradine Ameliorates Kidney Fibrosis in L-NAME-Induced Hypertension2020 | Faculty of Medicine in Hradec Králové